Tonix Pharmaceuticals Holding (TNXP) Earnings Date & Reports

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

TNXP is expected to report earnings to rise 104.71% to -2000 cents per share on May 12

Tonix Pharmaceuticals Holding TNXP Stock Earnings Reports

Q1'25

Est.

$-20.00

Q4'24

Missed

by $5.86

Q3'24

Beat

by $2.70

Q2'24

Missed

by $14.05

Q1'24

Beat

by $3.04

The last earnings report on March 18 showed earnings per share of -977 cents, missing the estimate of -391 cents. With 158.31K shares outstanding, the current market capitalization sits at 111.90M.

View a ticker or compare two or three

Compare

TNXP